Display options
Share it on

World J Emerg Surg. 2013 Apr 01;8(1):13. doi: 10.1186/1749-7922-8-13.

Fournier's gangrene: our experience with 50 patients and analysis of factors affecting mortality.

World journal of emergency surgery : WJES

El Bachir Benjelloun, Tarik Souiki, Nadia Yakla, Abdelmalek Ousadden, Khalid Mazaz, Abdellatif Louchi, Nabil Kanjaa, Khalid Ait Taleb

Affiliations

  1. Department of surgery, University hospital Hassan II, Fez, Morocco. [email protected].

PMID: 23547796 PMCID: PMC3616831 DOI: 10.1186/1749-7922-8-13

Abstract

INTRODUCTION: Fournier's gangrene is a rare, rapidly progressive, necrotizing fasciitis of the external genitalia and perineum. Case series have shown a mortality rate of 20% to 40% with an incidence of as high as 88% in some reports. In this study we aimed to share our experience in the management of Fournier's gangrene and to identify risk factors that affect mortality.

METHODS: The medical records of 50 patients with Fournier's gangrene who presented at the University Hospital Hassan II of Fez from January 2003 to December 2009 were reviewed retrospectively to analyze the outcome and identify the risk factors and prognostic indicators of mortality.

RESULTS: Ten males and five females were enrolled in the study. The mean age was 54 years (range 23-81). The most common predisposing factor was diabetes mellitus (34%). E. coli was the most frequent bacterial organisms cultured. All patients were treated with a common approach of resuscitation, broad-spectrum antibiotics, and wide surgical excision. The mortality rate was 24%. The advanced age, renal failure on admission, extension of infection to the abdominal wall, occurrence of septic shock and need for postoperative mechanical ventilation are the main prognostic factors of mortality. In multivariate analysis, none of these variables is an independent predictor of mortality.

CONCLUSIONS: Fournier's gangrene is still a very severe disease with high mortality rates. Early recognition of infection associated with invasive and aggressive treatment is essential for attempting to reduce these prognostic indices.

References

  1. Tunis Med. 2012 Oct;90(10):708-14 - PubMed
  2. Br J Surg. 2000 Jun;87(6):718-28 - PubMed
  3. Am Surg. 1999 Dec;65(12):1156-9 - PubMed
  4. BJU Int. 1999 Jul;84(1):85-8 - PubMed
  5. Urology. 2004 Aug;64(2):218-22 - PubMed
  6. Dis Colon Rectum. 2003 May;46(5):649-52 - PubMed
  7. Eur Urol. 2006 Oct;50(4):838-43 - PubMed
  8. BJU Int. 2012 Nov;110(9):1359-65 - PubMed
  9. Arch Esp Urol. 2009 Sep;62(7):532-40 - PubMed
  10. J Urol. 1984 Feb;131(2):289-91 - PubMed
  11. Surg Clin North Am. 2002 Dec;82(6):1213-24 - PubMed
  12. J Postgrad Med. 2008 Apr-Jun;54(2):102-5 - PubMed
  13. World J Surg. 2006 Sep;30(9):1750-4 - PubMed
  14. Asian J Surg. 2012 Jan;35(1):37-41 - PubMed
  15. Int J Urol. 2005 Dec;12(12):1041-4 - PubMed
  16. J Cutan Aesthet Surg. 2012 Oct;5(4):273-6 - PubMed
  17. Eur J Trauma Emerg Surg. 2011 Apr;37(2):141-5 - PubMed
  18. S Afr J Surg. 2012 Feb 14;50(1):16-9 - PubMed
  19. World J Surg. 2007 Sep;31(9):1858-1862 - PubMed
  20. Urol Int. 2012;89(2):173-9 - PubMed
  21. Urol Clin North Am. 1992 Feb;19(1):149-62 - PubMed
  22. Tech Coloproctol. 2010 Sep;14(3):217-23 - PubMed
  23. Urology. 2010 May;75(5):1193-8 - PubMed
  24. Presse Med. 2008 May;37(5 Pt 1):760-6 - PubMed
  25. Br J Urol. 1998 Mar;81(3):347-55 - PubMed
  26. Urology. 2000 Jul;56(1):31-5; discussion 35-6 - PubMed
  27. Urology. 2002 Nov;60(5):775-9 - PubMed
  28. Surg Gynecol Obstet. 1990 Jan;170(1):49-55 - PubMed
  29. J Urol. 2009 Dec;182(6):2742-7 - PubMed
  30. Langenbecks Arch Surg. 2010 Feb;395(2):173-80 - PubMed
  31. J Pak Med Assoc. 2010 Aug;60(8):617-9 - PubMed
  32. BJU Int. 2012 Dec;110(11 Pt C):E1096-100 - PubMed
  33. Singapore Med J. 2012 Aug;53(8):537-40 - PubMed
  34. J Urol. 1995 Jul;154(1):89-92 - PubMed
  35. Urol Int. 2012;89(4):457-61 - PubMed

Publication Types